These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 2183159)

  • 41. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
    Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
    Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenes and avian development.
    Dieterlen-Lievre F; Jaffredo T; Bachnou N; al Moustafa AE; Saule S
    Int J Dev Biol; 1990 Mar; 34(1):61-8. PubMed ID: 2168200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods.
    Carpenter PM; Mercola M; Mercola D
    Antisense Res Dev; 1991; 1(3):289-95. PubMed ID: 1821651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proto-oncogene expression in avian hematopoietic tissues.
    Schuur ER; Baluda MA
    Oncogene; 1991 Aug; 6(8):1409-15. PubMed ID: 1886713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host range restrictions of oncogenes: myc genes transform avian but not mammalian cells and mht/raf genes transform mammalian but not avian cells.
    Li R; Zhou RP; Duesberg P
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7522-7. PubMed ID: 8755507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL; Cory S; Adams JM
    Nature; 1988 Sep; 335(6189):440-2. PubMed ID: 3262202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas.
    Delia D; Borrello MG; Berti E; Pierotti MA; Biassoni D; Gianotti R; Alessi E; Rizzetti MG; Caputo R; Della Porta G
    Cancer Res; 1989 Sep; 49(17):4901-5. PubMed ID: 2503246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential.
    Symonds G; Hartshorn A; Kennewell A; O'Mara MA; Bruskin A; Bishop JM
    Oncogene; 1989 Mar; 4(3):285-94. PubMed ID: 2649846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of transformation by the v-rel oncogene.
    Hannink M; Temin HM
    Crit Rev Oncog; 1991; 2(4):293-309. PubMed ID: 1958712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
    Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
    Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines.
    Kalimi GH; Hampton LL; Trosko JE; Thorgeirsson SS; Huggett AC
    Mol Carcinog; 1992; 5(4):301-10. PubMed ID: 1379816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Six amino acids from the retroviral gene gag greatly enhance the transforming potential of the oncogene v-erb-B.
    Bruskin A; Jackson J; Bishop JM; McCarley DJ; Schatzman RC
    Oncogene; 1990 Jan; 5(1):15-24. PubMed ID: 1969616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid induction of plasmacytomas in mice by pristane and a murine recombinant retrovirus containing an avian v-myc and a defective raf oncogene.
    Potter M; Wax J; Mushinski E; Brust S; Babonits M; Wiener F; Mushinski JF; Mezebish D; Skurla R; Rapp U
    Curr Top Microbiol Immunol; 1986; 132():40-3. PubMed ID: 3792042
    [No Abstract]   [Full Text] [Related]  

  • 56. Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenes.
    Scully JL; Edwards PA
    Int J Cancer; 1991 Apr; 48(1):128-35. PubMed ID: 1826898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity.
    Stapleton P; Takayama Y; Hartshorn A; Kalaizis A; Rowe PB; Symonds G
    Oncogene; 1991 May; 6(5):807-17. PubMed ID: 1711191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of myb expression in an aggressive SJL/J B-cell lymphoma.
    Sopchak L; Thrush GR; Lerman SP; King SR
    Oncogene; 1991 Aug; 6(8):1335-8. PubMed ID: 1886709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenesis of the v-mht/mil oncogene in avian carcinoma virus MH2.
    Kan NC
    Avian Dis; 1991; 35(4):941-9. PubMed ID: 1786024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S; Söderkvist P
    Mutat Res; 2000 Jul; 452(1):19-26. PubMed ID: 10894886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.